Zhou D, Mayberg M R, London S, Gajdusek C
Department of Neurological Surgery, University of Washington, Seattle, USA.
Neurosurgery. 1996 Nov;39(5):991-7. doi: 10.1097/00006123-199611000-00021.
Although lipid peroxidation and alterations in endogenous antioxidants have been hypothesized to contribute to cerebral vasospasm after subarachnoid hemorrhage, there has been no direct evidence demonstrating the relationship between oxidative stress and delayed arterial narrowing. To elaborate the role of the endogenous intracellular antioxidant and electron exchanger glutathione (GSH) in cerebral vasospasm, rat femoral arteries were treated with perivascular application of I-buthionine-(SR)-sulfoximine (BSO), which inhibits the synthesis of GSH.
To determine the dose-response relationship, BSO at doses of 10 to 100 mg/ml, in platelet-rich plasma, was applied for 7 days to rat femoral arteries in vivo. Vessels were then perfusion-fixed for morphometric analysis of luminal cross-sectional area. To determine the time course of arterial narrowing, BSO (75 mg/ml) was applied to femoral arteries for 1, 3, 7, or 21 days before histological analysis, as described above. With rats treated with 50 to 100 mg/ml BSO, exogenous GSH (100 mg/kg) was administered, by intraperitoneal injection, daily for 7 days. To demonstrate the mechanism of BSO effects in smooth muscle cells (SMCs), cultured rat aortic SMCs were treated with 1 mmol/l BSO for 24 hours and assayed for intracellular levels of GSH and two products of lipid peroxidation, malondialdehyde and 4-hydroxyalkenal.
Compared with control arteries treated with platelet-rich plasma alone, perivascularly administered BSO applied for periods of 1 to 21 days produced sustained and reversible narrowing of rat femoral arteries with a time course, severity, and histological appearance analogous to those observed after perivascular application of whole blood. BSO-induced arterial narrowing was dose-dependent, with 60% reductions in the luminal cross-sectional area being noted at 75 and 100 mg/ml (P < 0.005). Systemic administration of exogenous GSH slightly inhibited the effect of BSO on arterial narrowing, although the inhibition was not statistically significant. Cultured rat aortic SMCs exposed to BSO for 24 hours showed a 70% decrease in intracellular GSH levels (P = 0.03); levels of two products of lipid peroxidation, malondialdehyde and 4-hydroxyalkenal, were increased by 25% (P = 0.24) and 38% (P = 0.09), respectively.
These data support the hypothesis that diminished intracellular levels of GSH may produce delayed chronic arterial narrowing after subarachnoid hemorrhage. The specific mechanism by which GSH levels modulate vasoconstriction remains uncertain but may involve endogenous antioxidant capacity in SMCs.
尽管有人提出脂质过氧化和内源性抗氧化剂的改变可能导致蛛网膜下腔出血后脑血管痉挛,但尚无直接证据证明氧化应激与延迟性动脉狭窄之间的关系。为阐明内源性细胞内抗氧化剂及电子交换剂谷胱甘肽(GSH)在脑血管痉挛中的作用,对大鼠股动脉进行血管周围应用L-丁硫氨酸-(S)-亚砜亚胺(BSO)处理,该物质可抑制GSH的合成。
为确定剂量反应关系,将富含血小板血浆中浓度为10至100mg/ml的BSO应用于大鼠股动脉体内7天。然后对血管进行灌注固定,以进行管腔横截面积的形态计量分析。为确定动脉狭窄的时间进程,如上述,在组织学分析前,将BSO(75mg/ml)应用于股动脉1、3、7或21天。对用50至100mg/ml BSO处理的大鼠,通过腹腔注射每日给予外源性GSH(100mg/kg),持续7天。为证明BSO对平滑肌细胞(SMC)作用的机制,将培养的大鼠主动脉SMC用1mmol/L BSO处理24小时,并检测细胞内GSH水平及脂质过氧化的两种产物丙二醛和4-羟基壬烯醛。
与仅用富含血小板血浆处理的对照动脉相比,血管周围应用1至21天的BSO可使大鼠股动脉产生持续且可逆的狭窄,其时间进程、严重程度及组织学表现与血管周围应用全血后观察到的相似。BSO诱导的动脉狭窄呈剂量依赖性,在75和100mg/ml时管腔横截面积减少60%(P<0.005)。全身给予外源性GSH对BSO所致动脉狭窄的作用有轻微抑制,尽管这种抑制无统计学意义。暴露于BSO 24小时的培养大鼠主动脉SMC细胞内GSH水平降低70%(P=0.03);脂质过氧化的两种产物丙二醛和4-羟基壬烯醛的水平分别升高25%(P=0.24)和38%(P=0.09)。
这些数据支持以下假说,即蛛网膜下腔出血后细胞内GSH水平降低可能导致延迟性慢性动脉狭窄。GSH水平调节血管收缩的具体机制尚不确定,但可能涉及SMC中的内源性抗氧化能力。